Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Mizuguchi

Showing results (211-220 of 406) with videos related to

Pageof 41
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 9, 2017
Transduction Properties of Adenovirus Serotype 35 Vectors After Intravenous Administration Into Nonhuman PrimatesFuminori Sakurai, Shin-Ichiro Nakamura, Kimiyo Akitomo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 12, 2017
miR-122a-Regulated Expression of a Suicide Gene Prevents Hepatotoxicity Without Altering Antitumor Effects in Suicide Gene TherapyTakayuki Suzuki, Fuminori Sakurai, Shin-Ichiro Nakamura, et al.
Stem Cell Research & Therapy|February 29, 2024
Functional intestinal monolayers from organoids derived from human iPS cells for drug discovery researchTatsuya Inui, Yusei Uraya, Jumpei Yokota, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 3, 2009
Prevention of hepatic ischemia-reperfusion injury by pre-administration of catalase-expressing adenovirus vectorsMasahiro Ushitora, Fuminori Sakurai, Tomoko Yamaguchi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 26, 2008
Transduction properties of adenovirus serotype 35 vectors after intravenous administration into nonhuman primatesFuminori Sakurai, Shin-ichiro Nakamura, Kimiyo Akitomo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 31, 2008
miR-122a-regulated expression of a suicide gene prevents hepatotoxicity without altering antitumor effects in suicide gene therapyTakayuki Suzuki, Fuminori Sakurai, Shin-ichiro Nakamura, et al.
Iscience|September 16, 2024
Development of a hepatic differentiation method in 2D culture from primary human hepatocyte-derived organoids for pharmaceutical researchYukiko Ueyama-Toba, Yanran Tong, Jumpei Yokota, et al.
Cancer Science|April 10, 2022
Tumor-targeted fluorescence labeling systems for cancer diagnosis and treatmentHiroshi Tazawa, Kunitoshi Shigeyasu, Kazuhiro Noma, et al.
Hepatology Communications|August 25, 2021
<i>In Vitro</i> Model for a Drug Assessment of Cytochrome P450 Family 3 Subfamily A Member 4 Substrates Using Human Induced Pluripotent Stem Cells and Genome Editing TechnologySayaka Deguchi, Tomohiro Shintani, Kazuo Harada, et al.
Biochemical and Biophysical Research Communications|November 19, 2011
Use of human hepatocyte-like cells derived from induced pluripotent stem cells as a model for hepatocytes in hepatitis C virus infectionTakeshi Yoshida, Kazuo Takayama, Masuo Kondoh, et al.
Pageof 41

Showing results (211-220 of 406) with videos related to

Sort By:
Pageof 41
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 9, 2017
Transduction Properties of Adenovirus Serotype 35 Vectors After Intravenous Administration Into Nonhuman PrimatesFuminori Sakurai, Shin-Ichiro Nakamura, Kimiyo Akitomo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 12, 2017
miR-122a-Regulated Expression of a Suicide Gene Prevents Hepatotoxicity Without Altering Antitumor Effects in Suicide Gene TherapyTakayuki Suzuki, Fuminori Sakurai, Shin-Ichiro Nakamura, et al.
Stem Cell Research & Therapy|February 29, 2024
Functional intestinal monolayers from organoids derived from human iPS cells for drug discovery researchTatsuya Inui, Yusei Uraya, Jumpei Yokota, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 3, 2009
Prevention of hepatic ischemia-reperfusion injury by pre-administration of catalase-expressing adenovirus vectorsMasahiro Ushitora, Fuminori Sakurai, Tomoko Yamaguchi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 26, 2008
Transduction properties of adenovirus serotype 35 vectors after intravenous administration into nonhuman primatesFuminori Sakurai, Shin-ichiro Nakamura, Kimiyo Akitomo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 31, 2008
miR-122a-regulated expression of a suicide gene prevents hepatotoxicity without altering antitumor effects in suicide gene therapyTakayuki Suzuki, Fuminori Sakurai, Shin-ichiro Nakamura, et al.
Iscience|September 16, 2024
Development of a hepatic differentiation method in 2D culture from primary human hepatocyte-derived organoids for pharmaceutical researchYukiko Ueyama-Toba, Yanran Tong, Jumpei Yokota, et al.
Cancer Science|April 10, 2022
Tumor-targeted fluorescence labeling systems for cancer diagnosis and treatmentHiroshi Tazawa, Kunitoshi Shigeyasu, Kazuhiro Noma, et al.
Hepatology Communications|August 25, 2021
<i>In Vitro</i> Model for a Drug Assessment of Cytochrome P450 Family 3 Subfamily A Member 4 Substrates Using Human Induced Pluripotent Stem Cells and Genome Editing TechnologySayaka Deguchi, Tomohiro Shintani, Kazuo Harada, et al.
Biochemical and Biophysical Research Communications|November 19, 2011
Use of human hepatocyte-like cells derived from induced pluripotent stem cells as a model for hepatocytes in hepatitis C virus infectionTakeshi Yoshida, Kazuo Takayama, Masuo Kondoh, et al.
Pageof 41